PuSH - Publikationsserver des Helmholtz Zentrums München

39 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Christophersen, I.E.* et al.: Fifteen genetic loci associated with the electrocardiographic P wave. Circ. Cardiovasc. Genet. 10:e001667 (2017)
2.
Mayosi, B.M.* et al.: Identification of cadherin 2 (CDH2) mutations in arrhythmogenic right ventricular cardiomyopathy. Circ. Cardiovasc. Genet. 10:e001605 (2017)
3.
Crotti, L.* et al.: Genetic modifiers for the long-QT syndrome: How important Is the role of variants in the 3' untranslated region of KCNQ1? Circ. Cardiovasc. Genet. 9, 330-339 (2016)
4.
Crotti, L.* et al.: Response by Crotti et al to letter regarding article, "Genetic modifiers for the long-QT syndrome: How important is the role of variants in the 3 ' untranslated region of KCNQ1?" Circ. Cardiovasc. Genet. 9, 581-582 (2016)
5.
Golbus, J.R.* et al.: Common and rare genetic variation in CCR2, CCR5, or CX3CR1 and risk of atherosclerotic coronary heart disease and glucometabolic traits. Circ. Cardiovasc. Genet. 9, 250-258 (2016)
6.
Joehanes, R.* et al.: Epigenetic signatures of cigarette smoking. Circ. Cardiovasc. Genet. 9, 436-447 (2016)
7.
Lacruz, M.E.* et al.: Cardiovascular risk factors associated with blood metabolite concentrations and their alterations over a 4-year period in a population-based cohort. Circ. Cardiovasc. Genet. 9, 487-494 (2016)
8.
Milano, A.* et al.: Sudden cardiac arrest and rare genetic variants in the community. Circ. Cardiovasc. Genet. 9, 147-153 (2016)
9.
Parmar, P.G.* et al.: International genome-wide association study consortium identifies novel loci associated with blood pressure in children and adolescents. Circ. Cardiovasc. Genet. 9, 266-278 (2016)
10.
Asl, H.F.* et al.: Expression quantitative trait loci acting across multiple tissues are enriched in inherited risk for coronary artery disease. Circ. Cardiovasc. Genet. 8, 305-315 (2015)
11.
Kolder, I.C.* et al.: Analysis for genetic modifiers of disease severity in patients with long QT syndrome type 2. Circ. Cardiovasc. Genet. 8, 447-456 (2015)
12.
Lieb, W.* et al.: Genome-wide meta-analyses of plasma renin activity and concentration reveal association with the kininogen 1 and prekallikrein genes. Circ. Cardiovasc. Genet. 8, 131-140 (2015)
13.
Pfeiffer, L. et al.: DNA methylation of lipid-related genes affects blood lipid levels. Circ. Cardiovasc. Genet. 8, 334-342 (2015)
14.
Ross, S.* et al.: Effect of bile acid sequestrants on the risk of cardiovascular events: A mendelian randomization analysis. Circ. Cardiovasc. Genet. 8, 618-627 (2015)
15.
Schäfer, A.S.* et al.: Genetic evidence for PLASMINOGEN as a shared genetic risk factor of coronary artery disease and periodontitis. Circ. Cardiovasc. Genet. 8, 159-167 (2015)
16.
Zeller, T.* et al.: Molecular characterization of the NLRC4 expression in relation to interleukin-18 levels. Circ. Cardiovasc. Genet. 8, 717-726 (2015)
17.
de Villiers, C.P.* et al.: AKAP9 is a genetic modifier of congenital long-QT syndrome type 1. Circ. Cardiovasc. Genet. 7, 599-606 (2014)
18.
Holmes, M.V.* et al.: Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA(2))-V isoenzyme in coronary heart disease modified mendelian randomization analysis using PLA2G5 expression levels. Circ. Cardiovasc. Genet. 7, 144-150 (2014)
19.
Kronenberg, F.* et al.: Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circ. Cardiovasc. Genet. 7, 822-829 (2014)
20.
Lüneburg, N.* et al.: Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine. Circ. Cardiovasc. Genet. 7, 864-872 (2014)